Viking Therapeutics (VKTX) Interest Expenses (2014 - 2015)
Viking Therapeutics' (VKTX) quarterly Interest Expenses came in at $35253.0 in Q1 2015, up 1268.52% year-on-year from $2576.0 in Q1 2014, and up 1268.52% quarter-over-quarter from $2576.0 in Q1 2014.
Viking Therapeutics (VKTX) Interest Expenses (2014 - 2015) Analysis & Trends
Viking Therapeutics has disclosed Interest Expenses across 2 years of filings, most recently posting $35253.0 for Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Viking Therapeutics | 3.50 Bn | 3.50 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 35,253.00 |
| Mar 31, 2015 | 35,253.00 |
| Mar 31, 2014 | 2,576.00 |
| Mar 31, 2014 | 2,576.00 |